Company intelligence / Profile preview
Ingenus Pharmaceuticals
Orlando, Florida, United Statesingenus.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
Ingenus Pharmaceuticals develops and manufactures a range of complex generic drugs with commercialized products in oncology and cardiology. Its flagship product, liquid cyclophosphamide injection, has been successfully licensed to Dr. Reddy’s for US commercialization. The company also launched the first-generic ivabradine hydrochloride tablets for heart failure through a partnership with Centaur Pharma. Clinical results are consistent with approved generics—no novel clinical data as the focus is on bioequivalence.
- Therapeutic areas
- CardiovascularOncologyOther
- Modalities
- Small moleculeGeneric drug formulations
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Dr. Reddy’s Laboratories Ltd.Athenex Pharmaceutical Division/APDCentaur Pharmaceuticals Ltd.
Beyond the preview
Go deeper on Ingenus Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ingenus Pharmaceuticals.